A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer
- PMID: 10811477
- DOI: 10.1038/sj.cgt.7700147
A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer
Abstract
When NIH 3T3 fibroblasts were transduced with a retroviral vector containing a cDNA for porcine pancreatic elastase 1 and cultured in the presence of affinity-purified human plasminogen, the exogenously added plasminogen was digested to generate the kringle 1-3 segment known as angiostatin, a potent angiogenesis inhibitor. This was evidenced by immunoblot analysis of the plasminogen digests using a monoclonal antibody specifically reacting with the kringle 1-3 segment, and by efficient inhibition of proliferation of human umbilical vein endothelial cells by the plasminogen digests isolated from the culture medium of 3T3 fibroblasts. However, when Lewis lung carcinoma cells were transduced with the same vector and injected subcutaneously into mice in their back or via the tail vein, their growth at the injection sites or in the lungs was markedly suppressed compared with the growth of similarly treated nontransduced Lewis lung carcinoma cells. Nevertheless, the transduced cells were able to grow as avidly as the control cells in vitro. Assuming that the elastase 1 secreted from the transduced cells is likely to be exempt from rapid inhibition by its physiological inhibitor, alpha1-protease inhibitor, as shown in the inflammatory tissues, the elastase 1 secreted from the tumor cells may effectively digest the plasminogen that is abundantly present in the extravascular spaces and generate the kringle 1-3 segment in the vicinity of implanted tumor cell clusters. Although the selection of more profitable virus vectors and cells to be transduced awaits further studies, such a protease gene transfer strategy may provide us with a new approach to anti-angiogenesis gene therapy for malignant tumors and their metastasis in vivo.
Similar articles
-
Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.Hepatology. 2003 Mar;37(3):696-704. doi: 10.1053/jhep.2003.50077. Hepatology. 2003. PMID: 12601367
-
Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.EXS. 1997;79:273-94. EXS. 1997. PMID: 9002223 Review.
-
A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen.Gene Ther. 2002 Dec;9(23):1600-6. doi: 10.1038/sj.gt.3301805. Gene Ther. 2002. PMID: 12424612
-
Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.Cancer Gene Ther. 2001 Oct;8(10):719-27. doi: 10.1038/sj.cgt.7700370. Cancer Gene Ther. 2001. PMID: 11687895
-
Retroviral vector-mediated gene transfer into endothelial cells.Mol Biol Med. 1991 Apr;8(2):257-66. Mol Biol Med. 1991. PMID: 1806767 Review.
Cited by
-
Expression of angiostatin cDNA in human hepatocellular carcinoma cell line SMMC-7721 and its effect on implanted carcinoma in nude mice.World J Gastroenterol. 2004 May 15;10(10):1421-4. doi: 10.3748/wjg.v10.i10.1421. World J Gastroenterol. 2004. PMID: 15133846 Free PMC article.
-
Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma.J Exp Clin Cancer Res. 2008 Nov 4;27(1):60. doi: 10.1186/1756-9966-27-60. J Exp Clin Cancer Res. 2008. PMID: 18983651 Free PMC article.
-
The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies.Curr Atheroscler Rep. 2000 Sep;2(5):407-16. doi: 10.1007/s11883-000-0079-z. Curr Atheroscler Rep. 2000. PMID: 11122772 Review.
-
Angiogenesis, metastasis, and endogenous inhibition.J Neurooncol. 2000 Oct-Nov;50(1-2):173-80. doi: 10.1023/a:1006453428013. J Neurooncol. 2000. PMID: 11245277 Review.
-
IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.Oncogene. 2011 Nov 3;30(44):4498-508. doi: 10.1038/onc.2011.154. Epub 2011 May 23. Oncogene. 2011. PMID: 21602894 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical